CareDx Corp (CDNA): Stock Price

CareDx, Inc (CDNA) holds a leading position in non-invasive transplant monitoring, expecting growth driven by the stabilization of Medicare payments. This daily price action reflects an asset value of 77.56. The company is implementing autonomous DNA analysis systems featuring intelligent software, and its success is based on the commitment of highly qualified medical professionals to a shared scientific goal.

Share Price: CareDx Corp (CDNA) for 07/04/2022 - 11/14/2026

Metric breakdowns and analytics for CareDx (CDNA)

- stock quotes and analyst forecast:

Stock Price CareDx, Inc|CDNA - Consensus Target

- stock exchange capitalization data:

Market Capitalization CareDx Inc|CDNA - Business Value

- book capitalization information:

Net Assets per Single Share CareDx|CDNA - Accounting Capitalization|Market Capitalization to Book Value Ratio caredx.com|CDNA - Company Total Assets

- business debt structure and liquidity details:

- company profitability and valuation multiples indicators:

CDNA - Company Profit|Projected Future Earnings CareDx, Inc|CDNA - P/E Multiple|Future Price to Earnings CareDx Health|CDNA - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio CareDx Inc|CDNA - Profit before interest, taxes and amortization|Earnings per share for the last twelve months CareDx|CDNA - Net earnings per share for the last four quarters|Quarterly EPS earnings growth caredx.com|CDNA - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year CareDx, Inc

- sales revenue and business income indicators:

CDNA - Company Gross Revenue|Projected Sales Volume CareDx|CDNA - Market Cap to Revenue|Forward P/S Multiple CareDx Inc

Analysis of all company metrics:CareDx Corp

The price reflects the market equilibrium between buying demand and the supply of shares. By analyzing the direction of the market trend, an investor determines the current business value in real time. This metric is calculated as the last executed trade, consolidating market expectations and macroeconomic factors. For CareDx, Inc. (CDNA), quotes confirm financial stability. Steady demand for transplant diagnostics ensures a predictable cash flow, supporting the market value of the assets.

Who CareDx, Inc competes with